By a GenomeWeb Staff Reporter

NEW YORK (GenomeWeb News) – Scottish firm Sistemic today announced a master service agreement to use its SistemRNA suite of drug development tools to accelerate Redx Pharma's preclinical development pipeline of more than 250 new drug candidates.

The agreement follows a project between the two companies in which Sistemic "added significant value" to a lead program of Redx while saving significant costs, Sistemic said.

Financial and other terms of the agreement were not disclosed.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.

Sep
12
Sponsored by
PerkinElmer

This webinar will cover recent advances in the use of CRISPR for generating animal models and cell lines.